奧聯電子(300585.SZ)擬定增募資不超2億元 由控股股東認購
格隆匯 9 月 3日丨奧聯電子(300585.SZ)披露向特定對象發行股票預案,此次發行的募集資金總額不超過2億元(含2億元),扣除發行費用後全部用於補充流動資金。
此次發行數量按照募集資金總額除以發行價格確定,為不超過1543.2098萬股(含本數),未超過此次及發行前公司總股本的30%,即4800萬股。
公司控股股東廣西瑞盈資產管理有限公司(“瑞盈資產”)認購此次發行的股份構成關聯交易,此次向特定對象發行股票完成後,瑞盈資產認購的股份自此次向特定對象發行結束之日起36個月內不得轉讓。此次發行前,公司的控股股東為瑞盈資產、實際控制人為錢明飛,此次發行完成後,公司控股股東和實際控制人不會發生變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.